Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Nanomedicines have shown great potential in cancer therapy; in particular, the combination of chemotherapy and immunotherapy (namely chemoimmunotherapy) that is revolutionizing cancer treatment. Currently, most nanomedicines for chemoimmunotherapy are still in preclinical and clinical trials. Lipid-...
Saved in:
Main Authors: | Tianqi Wang (Author), Yusuke Suita (Author), Saradha Miriyala (Author), Jordan Dean (Author), Nikos Tapinos (Author), Jie Shen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy
by: Mengting Shi, et al.
Published: (2023) -
Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
by: Tong Gao, et al.
Published: (2023) -
Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
by: Xiaoxian Huang, et al.
Published: (2022) -
Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine-Rituximab
by: Wulyo Rajabto, et al.
Published: (2024) -
Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration
by: Junhan Wu, et al.
Published: (2024)